This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Learn what to include in a retirement checklist to enhance your planning. These essential tips will guide your retirement journey.
15,841 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Bitcoin climbs to $81,000 as markets brace for weekend volatility. Pi Network’s PI token slips again, sliding to arou...
What could happen to NuScale Power stock over the next five years? This article breaks down the catalysts, scenarios,...
When two comedy heavyweights end a years-long feud on a live Netflix roast, it becomes more than a moment of laughter...
Bank Of America boosts its Affirm Holdings target to $88 after a solid quarter, framing May 12 investor day as a cata...
As markets drift through midday trading, chipmakers steal the spotlight with AI-driven rallies. Oil concerns temper e...
A clear, investor-friendly breakdown of SRFM's Q1 2026 results. Learn what the srfm 2026 earnings transcript reveals ...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Steris (STE) offers a steady earnings narrative in a healthcare environment shaped by infection control needs. This a...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
A practical, down-to-earth look at Howmet’s 2026 earnings outlook. This guide breaks down drivers, risks, and actiona...